Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px
Organisation › Details

Argen-X (Argenx) (Group)

argenx is a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. We are focused on developing product candidates with the potential to be either first-in-class against novel targets or best-in-class against known, but complex, targets in order to treat diseases with a significant unmet medical need. Our ability to execute on this focus is enabled by our suite of differentiated technologies. Our SIMPLE Antibody™ Platform, based on the powerful llama immune system, allows us to exploit novel and complex targets, and our three antibody engineering technologies are designed to enable us to expand the therapeutic index of our product candidates. *

 

Period Start 2008-01-01 established
Product Industry therapeutic antibody
Persons Person Van Hauwermeiren, Tim (Argen-X 201101 CEO before Ablynx BusDev Manager before P&G)
  Person 2 Castaldi, Eric (Argen-X 201406– CFO before NicOx CFO)
     
Region Region Rotterdam
  Country Netherlands
  Street 5 Willemstraat
  City 4811 AH Breda
  Tel +31-763-030-488
    Address record changed: 2017-04-17
     
Basic data Employees n. a.
  Currency EUR
  Cash 85,000,000 (2017-03-31)
     
    * Document for �About Section�: Argen-X N.V. (Argenx). (4/13/17). "Press Release: Argenx Receives First Preclinical Milestone Payment in AbbVie Collaboration". Breda & Ghent.
     
   
Record changed: 2018-11-15

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px

More documents for Argen-X (Argenx) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px




» top